Literature DB >> 2960641

Microheterogeneity of HLA-DR4 haplotypes: DNA sequence analysis of LD"KT2" and LD"TAS" haplotypes.

P K Gregersen1, S M Goyert, Q L Song, J Silver.   

Abstract

We have isolated and sequenced cDNA clones corresponding to the polymorphic alpha and beta chains encoded by the DR and DQ subregions of two HLA-DR4 haplotypes, LD"KT2" and LD"TAS". These two haplotypes are distinguished on the basis of mixed lymphocyte culture typing. The data indicate that the designation of LD"TAS" as a distinct subtype from Dw13 is very likely due to amino acid differences in the DQ beta chain. In contrast, LD"KT2" differs from TAS and Dw13 by a single amino acid substitution at position 37 of the DR beta 1 chain. The functional and evolutionary significance of these polymorphisms is discussed.

Mesh:

Substances:

Year:  1987        PMID: 2960641     DOI: 10.1016/0198-8859(87)90046-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  11 in total

1.  A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis.

Authors:  M Ota; T Seki; K Kiyosawa; S Furuta; K Hino; T Kondo; H Fukushima; K Tsuji; H Inoko
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Nucleotide sequence of a novel HLA-DRB4B1 allele, DRB1*0409.

Authors:  J S Lanchbury; E E Jaeger; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain.

Authors:  E W Petersdorf; A G Smith; E M Mickelson; P J Martin; J A Hansen
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 4.  Evolution of HLA class-II genes and haplotypes.

Authors:  J Silver
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 5.  The structural basis of alloreactivity.

Authors:  R Lechler; G Lombardi
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

6.  Nomenclature for factors of the HLA system, 1989. The WHO Nomenclature Committee.

Authors: 
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

7.  Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.

Authors:  E Celis; R W Karr
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Aspartic acid at position 57 of DQ beta chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects.

Authors:  K Yamagata; H Nakajima; T Hanafusa; T Noguchi; A Miyazaki; J Miyagawa; M Sada; H Amemiya; T Tanaka; N Kono
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

9.  L cells expressing DQ molecules of the DR3 and DR4 haplotypes: reactivity patterns with mAbs.

Authors:  D S Monos; E Czanky; S J Ono; S F Radka; D Kappes; J L Strominger
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Detection of novel sequence heterogeneity and haplotypic diversity of HLA class II genes.

Authors:  P Santamaria; M T Boyce-Jacino; A L Lindstrom; J J Barbosa; A J Faras; S S Rich
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.